Rush-Riverside Cancer Center — Kankakee, Illinois

Rush-Riverside Cancer Center is a clinical research site located in Kankakee, Illinois, United States 60901.

Crixeo Health Trust Score: 49/100 (POOR). This profile has not yet been claimed by the site owner.

Rush-Riverside Cancer Center has participated in 2 clinical trials.

Therapeutic areas: Drug/Agent Toxicity by Tissue/Organ, Leukemia, Myelodysplastic Syndromes.

Sponsors: Rush University Medical Center.

Sponsor Feasibility Report

Trust Score: 49/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rush-Riverside Cancer Center?

Rush-Riverside Cancer Center has a Crixeo Trust Score of 49/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rush-Riverside Cancer Center conducted?

Rush-Riverside Cancer Center has 2 clinical trials on record. Their work covers Drug/Agent Toxicity by Tissue/Organ, Leukemia, Myelodysplastic Syndromes.

Is Rush-Riverside Cancer Center accredited by Crixeo Health?

Rush-Riverside Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Rush-Riverside Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.